| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/25/1997 | US5614549 High molecular weight polymer-based prodrugs |
| 03/25/1997 | US5614547 Small molecule inhibitors of rotamase enzyme |
| 03/25/1997 | US5614546 Antiparasitic agents |
| 03/25/1997 | US5614545 Eye disorders, antiinflammatory agents using nitroimidazole compound with carriers |
| 03/25/1997 | US5614543 1-(aryloxyalkyl)-3- (heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics |
| 03/25/1997 | US5614542 Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use |
| 03/25/1997 | US5614541 Pharmacologically active catechol derivatives |
| 03/25/1997 | US5614540 Compounds useful for treating allergic and inflammatory diseases |
| 03/25/1997 | US5614537 Enzyme inhibitors of proline hydroxylase for inhibition of collagen biosynthesis and deposition |
| 03/25/1997 | US5614536 Substituted N-aminoalkylmethane sulfanilide as antispasmodica |
| 03/25/1997 | US5614535 Adhesion receptor antagonists |
| 03/25/1997 | US5614534 Derivatives of β, β-dimethyl-4-piperidineethanamine as inhibitors of the cholesterol biosynthesis |
| 03/25/1997 | US5614532 Quinolone derivatives |
| 03/25/1997 | US5614531 Adhesion receptor antagonists |
| 03/25/1997 | US5614530 Gmp phosphodiesterase inhibitor, hypotensive |
| 03/25/1997 | US5614529 Inhibition of plasmodia parasites by camptothecin compounds |
| 03/25/1997 | US5614526 Use of phenoxy-piperzine derivatives |
| 03/25/1997 | US5614525 Salts of disulfonyl methane compounds which are useful as parasiticide agents |
| 03/25/1997 | US5614522 Retroviral protease inhibitors |
| 03/25/1997 | US5614521 Nerve growth factor |
| 03/25/1997 | US5614520 Compounds for treatment of gout or hyperuricemia |
| 03/25/1997 | US5614519 (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists |
| 03/25/1997 | US5614517 Treatment of neurological disorders influenced by gamma-aminobutyric acid receptors |
| 03/25/1997 | US5614516 12-aminopyridazinopyrroloisoquinoline compounds |
| 03/25/1997 | US5614515 Preventing tissue adhesion after surgery |
| 03/25/1997 | US5614514 Steroid esters |
| 03/25/1997 | US5614513 Release agent binder for vitamin d compounds and derivatives |
| 03/25/1997 | US5614510 Pharmaceutical composition with improved bioavailability of inositol phosphate |
| 03/25/1997 | US5614509 Pharmaceutical agents for preventing the development of tolerance during the treatment with benzodiazepine-receptor-binding active ingredients |
| 03/25/1997 | US5614508 Antiischemic agents, alzheimers, stroke or nervous system disorders |
| 03/25/1997 | US5614507 Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia |
| 03/25/1997 | US5614506 After angioplasty |
| 03/25/1997 | US5614502 High-pressure impulse transient drug delivery for the treatment of proliferative diseases |
| 03/25/1997 | US5614501 Plant extracts as animal growth regulators, they contain polyphenol and arabinogalactan and are digested by bifidobacteria |
| 03/25/1997 | US5614490 Administration of low dose hemoglobin to increase perfusion |
| 03/25/1997 | US5614489 Method and composition for treating the skin |
| 03/25/1997 | US5614407 Administering 6-(substituted amino)purine cytokinins |
| 03/25/1997 | US5614218 Capsule containing morphine salt |
| 03/25/1997 | US5614213 Use of estriol for treatment of climacteric osteoporosis |
| 03/25/1997 | US5614210 Transdermal device for the delivery of alfuzosin |
| 03/25/1997 | US5614208 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 03/25/1997 | US5614199 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic β-cyclodextrin derivatives, a process for the preparation thereof and the use thereof |
| 03/25/1997 | US5614198 Bowman-Birk Inhibitor compositions for treatment of inflammatory disease |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | US5614171 Hydrophilic pharmaceutical composition containing ketoprofen lysine salt for topical use |
| 03/25/1997 | US5613944 Plasma-like substance |
| 03/25/1997 | US5613494 Ultrasonic contrast agent, microparticles containing a gas |
| 03/25/1997 | CA2139109C Purinone antianginal agents |
| 03/25/1997 | CA2092287C Controlled release verapamil tablet |
| 03/25/1997 | CA2080040C Methods for preventing mycobacterial infections by administration of rifabutin |
| 03/25/1997 | CA2067816C Muscarinic receptor antagonists |
| 03/25/1997 | CA2067178C Solid tumor treatment method and composition |
| 03/25/1997 | CA2039473C Rice dextrin oral rehydration solution |
| 03/25/1997 | CA1339022C Lactam derivatives |
| 03/25/1997 | CA1339021C Ó-crystals of cefazolin sodium |
| 03/25/1997 | CA1339015C Macrocyclic chelates and methods of use thereof |
| 03/25/1997 | CA1339008C Amphotericin b liposome preparation |
| 03/20/1997 | WO1997010493A1 METHOD FOR MEASURING NITROSYL (FeII)-HEMOGLOBIN |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010334A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | WO1997010332A2 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997010263A1 Actinomycin d analogues |
| 03/20/1997 | WO1997010257A1 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 03/20/1997 | WO1997010256A1 Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents |
| 03/20/1997 | WO1997010254A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | WO1997010249A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | WO1997010245A1 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT |
| 03/20/1997 | WO1997010244A1 NAPHTHAMIDE DERIVATIVES OF 3 β-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS |
| 03/20/1997 | WO1997010240A1 Phenol derivatives with pharmaceutical activity |
| 03/20/1997 | WO1997010239A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| 03/20/1997 | WO1997010238A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 03/20/1997 | WO1997010236A1 Esters of non-steroidal anti-inflammatory carboxylic acids |
| 03/20/1997 | WO1997010235A1 5-AMIDOMETHYL α, β-SATURATED AND -UNSATURATED 3-ARYL BUTYROLACTONE ANTIBACTERIAL AGENTS |
| 03/20/1997 | WO1997010234A1 Hydrolysis-promoting taxane hydrophobic derivatives |
| 03/20/1997 | WO1997010230A1 Diarylalkenylamine derivatives |
| 03/20/1997 | WO1997010229A1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 03/20/1997 | WO1997010227A1 Benzothiazolone derivatives |
| 03/20/1997 | WO1997010225A1 Pyrrolidine and thiazole derivatives with antibacterial and metallo-beta-lactamase inhibitory properties |
| 03/20/1997 | WO1997010223A1 Aminoaryl oxazolidinone n-oxides |
| 03/20/1997 | WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
| 03/20/1997 | WO1997010218A1 Cyclic nitrones and pharmaceutical compositions containing them |
| 03/20/1997 | WO1997010217A1 4-azasteroids for treatment of hyperandrogenic conditions |
| 03/20/1997 | WO1997010216A1 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals |
| 03/20/1997 | WO1997010214A1 Novel phenylacetic acid derivatives and medicinal composition containing the same |
| 03/20/1997 | WO1997010212A1 Piperidine compounds as calcium channel blockers |
| 03/20/1997 | WO1997010211A1 Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/20/1997 | WO1997010210A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists |
| 03/20/1997 | WO1997010207A1 Novel benzamide derivatives |
| 03/20/1997 | WO1997010205A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 03/20/1997 | WO1997010204A1 L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 03/20/1997 | WO1997010186A1 Photocatalytic coating substrate |
| 03/20/1997 | WO1997010005A2 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 03/20/1997 | WO1997010002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | WO1997010001A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | WO1997010000A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009997A1 Cystic fibrosis therapy |
| 03/20/1997 | WO1997009996A1 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 03/20/1997 | WO1997009994A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |